Page last updated: 2024-11-07

spironolactone and Dyskinesia Syndromes

spironolactone has been researched along with Dyskinesia Syndromes in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teive, HA1
Munhoz, RP1
Werneck, LC1
Selye, H1
Szabo, S1
Kourounakis, P1

Other Studies

2 other studies available for spironolactone and Dyskinesia Syndromes

ArticleYear
Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Aug-15, Volume: 22, Issue:11

    Topics: Aged; Gynecomastia; Heart Failure; Humans; Male; Mineralocorticoid Receptor Antagonists; Movement Di

2007
Protection by catatoxic steroids, phenobarbital and diphenylhydantoin against methaqualone intoxication.
    Steroids and lipids research, 1972, Volume: 3, Issue:2

    Topics: Androstenes; Animals; Enzyme Induction; Ethylestrenol; Female; Hydroxysteroids; Ketosteroids; Methaq

1972